13F-HR filed by DAFNA Capital Management LLC
DAFNA Capital Management LLC filed this 13F-HR for the quarter ended 2023-06-30, filed 2023-08-14, with 73 holding rows worth $365,729,922.
- Accession
- 0001389933-23-000008
- Filer
- CIK 1389933
- Filed
- 2023-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2023
A holdings report, 73 entries on the cover page, a total value of $365,729,922 stated on the cover page (in dollars after the unit check, H1), rows summing to $365,729,922 with VALUE read as dollars as filed, 13F file number 028-12327. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerFischel Nathan028-12328
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SPDR SER TR | 78464A870 | S&P BIOTECH | 565,000 | $47,008,000 | dollars as filed | |
| IVERIC BIO INC | 46583P102 | COM | 612,975 | $24,114,437 | dollars as filed | |
| STEREOTAXIS INC | 85916J409 | COMMON STOCK | 13,680,554 | $20,931,248 | dollars as filed | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 251,521 | $15,896,127 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 512,285 | $13,703,624 | dollars as filed | |
| ISHARES TR | 464287556 | ISHARES BIOTECH | 102,500 | $13,013,400 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 135,212 | $12,067,671 | dollars as filed | |
| MORPHIC HLDG INC | 61775R105 | COM | 206,748 | $11,852,863 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 479,820 | $11,275,770 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 332,734 | $10,853,783 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 280,538 | $10,800,713 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 384,870 | $10,133,627 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 450,873 | $9,436,772 | dollars as filed | |
| KARUNA THERAPEUTICS INC | 48576A100 | COM | 42,173 | $9,145,215 | dollars as filed | |
| DEXCOM INC COM | 252131107 | Stock | 67,552 | $8,681,108 | dollars as filed | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 180,306 | $8,477,988 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 74,615 | $7,036,195 | dollars as filed | |
| ATRICURE INC | 04963C209 | COM | 125,529 | $6,196,111 | dollars as filed | |
| Day One Biopharmaceuticals Inc | 23954D109 | Common Stock | 507,100 | $6,054,774 | dollars as filed | |
| DICE THERAPEUTICS INC | 23345J104 | COM | 127,585 | $5,927,599 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 556,695 | $5,561,383 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 611,032 | $5,499,288 | dollars as filed | |
| 2SEVENTY BIO INC COMMON STOCK | 901384107 | Stock | 496,416 | $5,023,730 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 293,655 | $4,760,148 | dollars as filed | |
| ACCURAY INC DEL | 004397105 | COM | 1,222,358 | $4,730,525 | dollars as filed | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 225,717 | $4,584,312 | dollars as filed | |
| CENTURY THERAPEUTICS INC | 15673T100 | COM | 1,307,407 | $4,131,406 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 519,384 | $4,025,226 | dollars as filed | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 569,000 | $4,005,760 | dollars as filed | |
| ALECTOR INC | 014442107 | COMMON STOCK | 638,938 | $3,840,017 | dollars as filed | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 357,784 | $3,785,355 | dollars as filed | |
| Ascendis Pharma A/S | 04351PAD3 | Convertible bond | 4,000,000 | $3,627,500 | dollars as filed | principal |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 94,700 | $3,421,511 | dollars as filed | |
| BICYCLE THERAPEUTICS PLC-ADR | 088786108 | SPONSORED ADS | 122,200 | $3,118,544 | dollars as filed | |
| AXOGEN INC | 05463X106 | COM | 332,103 | $3,032,100 | dollars as filed | |
| MEDIWOUND LTD | M68830112 | COMMON STOCK | 257,653 | $2,746,581 | dollars as filed | |
| TANDEM DIABETES CARE INC | 875372203 | COM NEW | 110,000 | $2,699,400 | dollars as filed | |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 810,845 | $2,667,680 | dollars as filed | |
| AUTOLUS THERAPEUTICS PLC SPON | 05280R100 | COM | 930,394 | $2,214,338 | dollars as filed | |
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 52,675 | $2,141,766 | dollars as filed | |
| ADICET BIO INC | 007002108 | COM | 797,054 | $1,936,841 | dollars as filed | |
| KEROS THERAPEUTICS INC COM | 492327101 | Stock | 47,661 | $1,915,019 | dollars as filed | |
| REGULUS THERAPEUTICS INC | 75915K309 | COM | 1,111,049 | $1,633,242 | dollars as filed | |
| VIGIL NEUROSCIENCE INC | 92673K108 | COM | 172,308 | $1,619,695 | dollars as filed | |
| PROQR THERAPEUTICS NV | N71542109 | SHS EURO | 940,582 | $1,523,743 | dollars as filed | |
| LYRA THERAPEUTICS INC | 55234L105 | COM | 361,084 | $1,484,055 | dollars as filed | |
| MEREO BIOPHARMA GROUP PLC | 589492107 | CMN | 1,009,013 | $1,331,897 | dollars as filed | |
| ITEOS THERAPEUTICS INC | 46565G104 | COM | 98,560 | $1,304,934 | dollars as filed | |
| BRAINSWAY LTD | 10501L106 | CMN | 504,681 | $1,150,673 | dollars as filed | |
| SUTRO BIOPHARMA INC | 869367102 | COM | 242,779 | $1,128,922 | dollars as filed | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 350,373 | $1,096,667 | dollars as filed | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 127,653 | $1,063,349 | dollars as filed | |
| ACRIVON THERAPEUTICS INC | 004890109 | CMN | 76,852 | $996,002 | dollars as filed | |
| SURFACE ONCOLOGY INC | 86877M209 | COM | 1,100,000 | $956,560 | dollars as filed | |
| SYROS PHARMACEUTICALS INC | 87184Q206 | COM NEW | 265,878 | $837,516 | dollars as filed | |
| PARDES BIOSCIENCES INC | 69945Q105 | COM | 430,291 | $778,827 | dollars as filed | |
| NEVRO CORP | 64157F103 | COM | 28,000 | $711,760 | dollars as filed | |
| ELEVATION ONCOLOGY INC COM | 28623U101 | Stock | 450,000 | $684,000 | dollars as filed | |
| NEURONETICS INC | 64131A105 | COM | 313,717 | $674,492 | dollars as filed | |
| SPRUCE BIOSCIENCES INC | 85209E109 | COM | 312,000 | $670,800 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 21,113 | $505,023 | dollars as filed | |
| MASIMO CORP COM | 574795100 | Stock | 3,000 | $493,650 | dollars as filed | |
| COMPASS THERAPEUTICS INC | 20454B104 | COM | 116,882 | $371,685 | dollars as filed | |
| KARYOPHARM THERAPEUTICS INC | 48576U106 | COM | 192,678 | $344,894 | dollars as filed | |
| NEXTCURE INC | 65343E108 | COM | 187,696 | $337,853 | dollars as filed | |
| ADAPTIMMUNE THERAPEUTICS PLC | 00653A107 | SPONDS ADR | 351,064 | $324,734 | dollars as filed | |
| MEDICENNA THERAPEUTICS F | 58490H107 | FOREIGN CANADIAN | 660,000 | $317,922 | dollars as filed | |
| PROCEPT BIOROBOTICS CORP COM | 74276L105 | Stock | 8,000 | $282,800 | dollars as filed | |
| KINNATE BIOPHARMA INC | 49705R105 | COM | 80,179 | $242,942 | dollars as filed | |
| COMPUGEN LTD | M25722105 | ORD | 205,202 | $233,930 | dollars as filed | |
| LINEAGE CELL THERAPEUTICS IN | 53566P109 | COMMON STOCK | 140,000 | $197,400 | dollars as filed | |
| SPERO THERAPEUTICS INC | 84833T103 | COM | 125,000 | $181,250 | dollars as filed | |
| INOGEN INC | 45780L104 | COM | 15,000 | $173,250 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001389933-23-000008 | this filing | 2023-08-14 | acceptance time not in the bulk data set |